Pyrazole–β-Carboline Compound for HGC-27 Tumor Cell Inhibition
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for effective anti-cancer drugs that can inhibit tumor cells, particularly HGC-27 cells, as cancer incidence rates continue to rise.
Innovation Solution
A pyrazole compound containing a 1-(3,4-dimethoxyphenyl)-β-carboline unit is synthesized through specific reaction steps, combining intermediates using solvents like toluene, isopropyl alcohol, DMF, and ethanol, followed by silica gel column chromatography to purify the crude product.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional anti-cancer drugs are used, then tumor cells can be inhibited to some extent, but the efficacy is insufficient and resistance develops
Solution Approach 1:
The patent combines β-carboline and pyrazole into a composite molecular structure (compound I), integrating the anti-tumor active ingredients of both heterocyclic units. This composite structure enables synergistic anti-tumor effects while reducing the development of resistance, as the combined molecular architecture attacks tumor cells through multiple mechanisms simultaneously.
Solution Approach 2:
The patent modifies molecular parameters by introducing specific substituents (methoxy groups at positions 3 and 4 of the phenyl ring) and adjusting the chemical structure of the β-carboline-pyrazole conjugate. These structural parameter changes optimize the compound's binding affinity to tumor cells and enhance its anti-tumor activity while minimizing resistance development.
2Reliability
If new anti-cancer compounds are synthesized, then anti-tumor activity can be improved, but the preparation process becomes complex
Solution Approach 1:
The synthesis process is divided into discrete, manageable steps: (1) preparation of intermediate compounds (β-carboline acylhydrazine and pyrazole aldehyde), (2) coupling reaction to form the conjugate, and (3) purification. This segmentation allows each step to be optimized independently and facilitates reproducible synthesis of the anti-tumor compound.
Solution Approach 2:
The patent employs intermediate compounds (acylhydrazine and aldehyde intermediates) as mediators in the synthesis process. These intermediates serve as bridging structures that facilitate the formation of the final β-carboline-pyrazole conjugate through controlled chemical reactions, simplifying the overall synthesis pathway while maintaining high anti-tumor activity.
3Reliability
If existing heterocyclic compounds are used, then some anti-tumor effect is achieved, but the inhibitory activity against specific tumor cells is insufficient
Solution Approach 1:
The patent introduces local structural features at specific positions within the molecule - namely the 3,4-dimethoxy substitution pattern on the phenyl ring and the specific coupling position of the pyrazole unit. These localized structural modifications enhance the compound's affinity for HGC-27 gastric cancer cells specifically, improving inhibitory activity against this target while maintaining general anti-tumor effects.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The synthesized pyrazole compound demonstrates significant inhibitory activity against HGC-27 tumor cells, outperforming the standard drug 5-fluorouracil in efficacy.
Implementation Method 1
heating the reaction solution to reflux and react for 13 hours
Implementation Method 2
evaporating a solvent under reduced pressure
Implementation Method 3
evaporating a solvent under reduced pressure
Implementation Method 4
purifying the resulting crude product by silica gel column chromatography
Data Source
AI summary
The disclosure relates to a preparation method and use of a pyrazole compound containing 1-(3,4-dimethoxyphenyl)-β-carboline unit. The pyrazole compound is prepared by reacting pyrazole aldehyde and 1-(3,4-dimethoxyphenyl)-β-carboline acylhydrazine. The pyrazole compound containing 1-(3,4-dimethoxyphenyl)-β-carboline unit has good inhibitory activity against tumor cell HGC-27. The pyrazole compound could be used in the preparation of anti-tumor drugs.